Search results
Results from the WOW.Com Content Network
The CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) formula was first published in May 2009. It was developed in an effort to create a formula more accurate than the MDRD formula, especially when actual GFR is greater than 60 mL/min per 1.73 m 2. This is the formula currently recommended by NICE in the UK. [27]
"Summary of KDIGO 2012 CKD Guideline: behind the scenes, need for guidance, and a framework for moving forward". Kidney International. 85 (1): 49–61. doi: 10.1038/ki.2013.444. PMID 24284513. Co-author of textbook: “Chronic Kidney Disease: a practical guide to understanding and management”, ISBN 9780199549313
The severity of chronic kidney disease (CKD) is described by six stages; the most severe three are defined by the MDRD-eGFR value, and first three also depend on whether there is other evidence of kidney disease (e.g., proteinuria): 0) Normal kidney function – GFR above 90 (mL/min)/(1.73 m 2) and no proteinuria
All people with a GFR <60 mL/min/1.73 m 2 for 3 months are defined as having chronic kidney disease. [59] Protein in the urine is regarded as an independent marker for worsening of kidney function and cardiovascular disease. Hence, British guidelines append the letter "P" to the stage of chronic kidney disease if protein loss is significant. [60]
Scroll down for the full story! More info: Facebook. Everybody needs a hero sometimes, especially if you’re a 20-year-old blind cat stuck on a chunk of ice.
The outgoing Biden administration's top diplomat, Antony Blinken, heads to Brussels on Tuesday for talks with European allies concerned that President-elect Donald Trump could abandon Ukraine in ...
From January 2008 to December 2012, if you bought shares in companies when Constance J. Horner joined the board, and sold them when she left, you would have a -3.8 percent return on your investment, compared to a -2.8 percent return from the S&P 500.
[3] CKD–MBD broadens the "old" concept of "renal osteodystrophy", which now should be restricted to describing the bone pathology associated with CKD. [1] [2] Thus, renal osteodystrophy is currently considered one measure of the skeletal component of the systemic disorder of CKD–MBD that is quantifiable by histomorphometry of bone biopsy.